Cargando…
Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy
OBJECTIVES: To investigate the characteristics of different clinico-serologic subgroups of immune-mediated necrotizing myopathy (IMNM). METHODS: We retrospectively reviewed data from medical charts of 64 patients diagnosed with IMNM between 2012 and 2017 in 3 neuromuscular referral centers in The Ne...
Autores principales: | Lim, Johan, Rietveld, Anke, De Bleecker, Jan L., Badrising, Umesh A., Saris, Christiaan G.J., van der Kooi, Anneke J., de Visser, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192692/ https://www.ncbi.nlm.nih.gov/pubmed/30345336 http://dx.doi.org/10.1212/NXI.0000000000000513 |
Ejemplares similares
-
The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China
por: Ma, Xue, et al.
Publicado: (2021) -
Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review
por: Kamperman, Renske G., et al.
Publicado: (2022) -
Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report
por: Patel, Shriya, et al.
Publicado: (2022) -
Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study
por: Lim, Johan, et al.
Publicado: (2020) -
Prominent Asymmetric Muscle Weakness and Atrophy in Seronegative Immune-Mediated Necrotizing Myopathy
por: Park, Sunha, et al.
Publicado: (2021)